SuperworthAlzamend Neuro shares outstanding ALZN
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jul 31, 2026
- 4.5M
- On a year earlier
- +112.7%
- more shares
Alzamend Neuro had 4.5M diluted shares outstanding on average in Q1 FY27, the quarter to Jul 31, 2026.
That is 112.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 4M | +453% |
| FY2025 | 723.5K | +893% |
| FY2024 | 72.8K | +2% |
| FY2023 | 71.7K | +10% |
| FY2022 | 65.1K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q1 FY27 | 4.5M | +113% | |
| Q4 FY26 | 4M | +453% | |
| Q3 FY26 | 3.8M | +522% | |
| Q2 FY26 | 3.4M | +762% | |
| Q1 FY26 | 2.1M | +2369% | |
| Q4 FY25 | 723.5K | +893% | |
| Q3 FY25 | 612K | +681% | |
| Q2 FY25 | 392.4K | +438% | |
| Q1 FY25 | 85.3K | +17% | |
| Q4 FY24 | 72.8K | +2% | |
| Q3 FY24 | 78.4K | +8% | |
| Q2 FY24 | 72.9K | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Alzamend Neuro
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.